{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:51:48Z","timestamp":1791406308989,"version":"4.3.3"},"reference-count":34,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010564","name":"Deutsches Zentrum fur Lungenforschung e V","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jaip.2026.06.029","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T23:44:23Z","timestamp":1782949463000},"page":"2334-2340","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effectiveness of Treatment With Tezepelumab in Patients With Severe Asthma, Smoking Asthmatics and Patients With Severe Asthma and COPD: A Real-World Cohort Study"],"prefix":"10.1016","volume":"14","author":[{"given":"Nora","family":"Drick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Valtin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2926-3608","authenticated-orcid":false,"given":"Jan","family":"Fuge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2026.06.029_bib1","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1183\/09031936.00202013","article-title":"International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma","volume":"43","author":"Chung","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2026.06.029_bib2","doi-asserted-by":"crossref","DOI":"10.1183\/20734735.0133-2023","article-title":"Management of comorbidities in difficult and severe asthma","volume":"19","author":"Khan","year":"2023","journal-title":"Breathe"},{"key":"10.1016\/j.jaip.2026.06.029_bib3","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.anai.2023.08.021","article-title":"Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma Registry","volume":"132","author":"Scelo","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2026.06.029_bib4","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.04656-2020","article-title":"The coexistence of asthma and COPD: risk factors, clinical history and lung function trajectories","volume":"58","author":"Marcon","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2026.06.029_bib5","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1056\/NEJMra1411863","article-title":"The asthma\u2013COPD overlap syndrome","volume":"373","author":"Postma","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2026.06.029_bib6","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.chest.2021.09.036","article-title":"Asthma-COPD overlap","volume":"161","author":"Leung","year":"2022","journal-title":"CHEST"},{"key":"10.1016\/j.jaip.2026.06.029_bib7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s12931-019-1198-4","article-title":"Global prevalence of asthma-COPD overlap (ACO) in the general population: a systematic review and meta-analysis","volume":"20","author":"Hosseini","year":"2019","journal-title":"Respir Res"},{"key":"10.1016\/j.jaip.2026.06.029_bib8","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0140-6736(22)01273-9","article-title":"Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission","volume":"400","author":"Stolz","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2026.06.029_bib9","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S2213-2600(21)00511-7","article-title":"Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis","volume":"10","author":"Adeloye","year":"2022","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2026.06.029_bib10","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1159\/000534922","article-title":"Response to various biologics in patients with both asthma and chronic obstructive pulmonary disease","volume":"102","author":"Lommatzsch","year":"2023","journal-title":"Respiration"},{"key":"10.1016\/j.jaip.2026.06.029_bib11","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1056\/NEJMoa2034975","article-title":"Tezepelumab in adults and adolescents with severe, uncontrolled asthma","volume":"384","author":"Menzies-Gow","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2026.06.029_bib12","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/s12931-020-01503-z","article-title":"SOURCE: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel group trial to evaluate the efficacy and safety of tezepelumab in reducing oral corticosteroid use in adults with oral corticosteroid dependent asthma","volume":"21","author":"Wechsler","year":"2020","journal-title":"Respir Res"},{"key":"10.1016\/j.jaip.2026.06.029_bib13","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/S0140-6736(22)00331-2","article-title":"Disease-modifying anti-asthmatic drugs","volume":"399","author":"Lommatzsch","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2026.06.029_bib14","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.alit.2024.11.003","article-title":"Prevalence and clinical impact of asthma-COPD overlap in severe asthma","volume":"74","author":"Wakazono","year":"2025","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaip.2026.06.029_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-74966-1","article-title":"Comorbidity profile of patients with concurrent diagnoses of asthma and COPD in Germany","volume":"10","author":"Akmatov","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaip.2026.06.029_bib16","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/all.14483","article-title":"Characteristics of specialist-diagnosed asthma-COPD overlap in severe asthma: observations from the Korean Severe Asthma Registry (KoSAR)","volume":"76","author":"Lee","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2026.06.029_bib17","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1378\/chest.129.3.661","article-title":"Smoking and asthma","volume":"129","author":"Boulet","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2026.06.029_bib18","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1378\/chest.123.5.1472","article-title":"Cigarette smoking among asthmatic adults presenting to 64 emergency departments","volume":"123","author":"Silverman","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2026.06.029_bib19","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.jaip.2025.01.005","article-title":"Impact of smoking on biological treatment response in patients from the German Severe Asthma (GAN) Registry","volume":"13","author":"Stoshikj","year":"2025","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.06.029_bib20","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jaip.2023.10.012","article-title":"Tobacco exposure and efficacy of biologic therapy in patients with severe asthma: a nationwide study from the Danish Severe Asthma Register","volume":"12","author":"Baastrup Soendergaard","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.06.029_bib21","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0137-2019","article-title":"Minimal clinically important difference for asthma endpoints: an expert consensus report","volume":"29","author":"Bonini","year":"2020","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.jaip.2026.06.029_bib22","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1081\/COPD-200053377","article-title":"Minimal clinically important differences in COPD lung function","volume":"2","author":"Donohue","year":"2005","journal-title":"COPD"},{"key":"10.1016\/j.jaip.2026.06.029_bib23","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1164\/rccm.201310-1863PP","article-title":"Minimal clinically important differences in pharmacological trials","volume":"189","author":"Jones","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2026.06.029_bib24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S2213-2600(24)00324-2","article-title":"Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial","volume":"13","author":"Singh","year":"2025","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2026.06.029_bib25","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/ni.1852","article-title":"Sensing the outside world: TSLP regulates barrier immunity","volume":"11","author":"Ziegler","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaip.2026.06.029_bib26","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1056\/NEJMoa1402895","article-title":"Effects of an anti-TSLP antibody on allergen-induced asthmatic responses","volume":"370","author":"Gauvreau","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2026.06.029_bib27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1164\/rccm.202210-2005OC","article-title":"Efficacy of tezepelumab in severe, uncontrolled asthma: pooled analysis of the PATHWAY and NAVIGATOR clinical trials","volume":"208","author":"Corren","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2026.06.029_bib28","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1056\/NEJMoa2414482","article-title":"Tezepelumab in adults with severe chronic rhinosinusitis with nasal polyps","volume":"392","author":"Lipworth","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2026.06.029_bib29","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s12931-020-01513-x","article-title":"CASCADE: a phase 2, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the effect of tezepelumab on airway inflammation in patients with uncontrolled asthma","volume":"21","author":"Emson","year":"2020","journal-title":"Respir Res"},{"key":"10.1016\/j.jaip.2026.06.029_bib30","doi-asserted-by":"crossref","first-page":"00314","DOI":"10.1183\/23120541.00314-2025","article-title":"Real-world evidence of tezepelumab for severe asthma: a retrospective multicentre cohort","volume":"11","author":"Khateeb","year":"2025","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.jaip.2026.06.029_bib31","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S2213-2600(25)00359-5","article-title":"Oral corticosteroid reduction and discontinuation in adults with corticosteroid-dependent, severe, uncontrolled asthma treated with tezepelumab (WAYFINDER): a multicentre, single-arm, phase 3b trial","volume":"14","author":"Jackson","year":"2026","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2026.06.029_bib32","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jaip.2025.11.024","article-title":"Comparative effectiveness of tezepelumab and dupilumab in asthma: a multinational retrospective cohort study","volume":"14","author":"Hung","year":"2026","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.06.029_bib33","doi-asserted-by":"crossref","first-page":"00207","DOI":"10.1183\/23120541.00207-2022","article-title":"Treatment with interleukin (IL)-5\/IL-5 receptor antibodies in patients with severe eosinophilic asthma and COPD","volume":"8","author":"Drick","year":"2022","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.jaip.2026.06.029_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2023.100848","article-title":"A comparison of treatment response to biologics in asthma-COPD overlap and pure asthma: findings from the PRISM study","volume":"16","author":"Shim","year":"2023","journal-title":"World Allergy Organ J"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219826005271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219826005271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:58:25Z","timestamp":1791403105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219826005271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2213219826005271"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2026.06.029","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of Treatment With Tezepelumab in Patients With Severe Asthma, Smoking Asthmatics and Patients With Severe Asthma and COPD: A Real-World Cohort Study","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2026.06.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}